Mylo Medical's founder started on the front lines of care as a nursing assistant. Witnessing the side of healthcare that data and KPIs can never quantify — the human moments of vulnerability, exhaustion, and quiet suffering that come from tools built to treat conditions, not people; functional in theory, yet failing in practice.

One patient’s words revealed, more clearly than any metric ever could, what was truly broken. When the bedpan failed to preserve her dignity, she looked up at her through tears and said, "Nobody should have to live like this." Those words never left her — they became the lens through which she saw every flaw we’d learned to accept as normal.

That night marked the beginning of Mylo Medical – inspired by the belief that true innovation in healthcare begins with empathy. Across hospitals and nursing homes, there are countless devices waiting to be reimagined – reminders that design, compassion, and technology are not luxuries in medicine, but necessities.

Our mission is to disrupt the medical equipment industry, to lead that change – and to build a future where every product that touches a patient’s life does so with intelligence, humanity, and respect.

• Developed and validated early MyloPan™ prototypes informed by real-world clinical workflows
• Secured interest and early engagement from major healthcare distributors, facilities, and care networks
• Recognized as a Top Startup at the largest medical expo in the United States, selected among the Top Four companies overall
• Advanced manufacturing strategy through discussions with multiple domestic and international production partners
• Began building a formal Quality Management System (QMS) in preparation for regulatory readiness and scale
• Attracted early investor interest and assembled an initial group of mission-aligned supporters
• Expanded advisory and operational expertise to support product development, quality, and commercialization

Across hospitals and long-term care facilities, many essential patient-care products remain largely unchanged for decades.

Patients are left feeling exposed, uncomfortable, and stripped of dignity, while nurses are forced to work around tools that slow workflows, increase physical strain, and add unnecessary stress to already demanding shifts.

These issues persist despite clear shifts in healthcare priorities. Today’s care environment increasingly values patient dignity, comfort-focused care, infection awareness, and clinician well-being—yet many everyday tools lag far behind these expectations. Nurses experience burnout at alarming rates, and patient satisfaction is deeply influenced by moments that traditional metrics often overlook. This gap revealed a powerful truth: the very challenges patients and nurses face every day are not inevitable—they are design failures. Mylo Medical was founded on the belief that if we listened closely enough to those challenges, each one could become a feature, not a compromise.

MyloPan™ was built from that insight—designed by someone who lived the problem, for the people who carry the weight of care every day. Built for nurses, informed by patients, and grounded in the belief that dignity, comfort, and efficiency are not optional in healthcare—they are essential.

MyloPan™ was designed by starting where traditional solutions stop – by listening.

How MyloPan™ works, step by step:

Instead of forcing patients and nurses to adapt to a rigid, uncomfortable tool, MyloPan™ adapts to them. The system is designed to be positioned easily by a caregiver, providing stable support while prioritizing comfort and privacy for the patient. Its materials and form are intended to feel less clinical and more human, while simplifying handling, cleanup, and workflow for nursing staff. MyloPan uses soft durable material and easily conforms to a patient’s body contours. If needed it can be inserted under the patient and inflated without the need to lift the patient’s body - a major improvement over existing procedures that often require painful lifting of the patient.

How this differs from the current standard:

Traditional bedpans often require awkward positioning, cause severe discomfort, and leave patients feeling exposed. For nurses, they add physical strain, inefficiency, and stress during already demanding shifts. MyloPan™ reimagines this interaction entirely—transforming common pain points into intentional design features that support dignity, comfort, and ease of use.

Impact on real lives:

For patients, MyloPan™ helps restore a sense of dignity during some of their most vulnerable moments. For caregivers, it reduces friction in routine tasks, allowing them to focus more fully on care—not workarounds. These small moments matter. They shape how patients remember their care and how nurses experience their workday.

Mylo Medical exists to change the parts of healthcare people don’t talk about—but never forget. Because no one thinks about these moments until they’re living them.

Mylo Medical operates a multi-channel business model designed to support both large-scale healthcare adoption and individual patient access. Revenue plans to be generated through the sale of MyloPan™ units and associated consumables across three strategic tiers.

This three-tiered approach enables Mylo Medical to balance large-scale institutional partnerships with direct facility relationships and consumer accessibility—expanding impact while maintaining a consistent, patient-centered standard of care. Our intent is to own the marketplace by making MyloPan accessible to everyone. In addition, we intend to introduce MyloPan to global markets, especially Canada and Western European countries initially. We have an international team assembled to facilitate sales. In some markets like the UK, institutional sales are handled through a national entity making the sales process a bit more streamlined.

Mylo Medical’s initial market opportunity spans hospitals, long-term care, and at-home caregiving – segments driven by an aging population, high inpatient volume, and growing demand for dignity- and workflow-focused care.

Large and Recurring Institutional Demand:

Healthcare delivery is supported by a vast and highly utilized institutional infrastructure – creating consistent, recurring demand for essential patient-care solutions.

• Hospitals
  – U.S. hospitals see ~35.6 million total admissions annually
  – The U.S. has ~6,100 hospitals
  (AHA)
• Nursing Homes
  – ~14,700 nursing homes
  – ~1.6 million licensed beds
  – ~1.2 million residents
  (CDC / NCHS FastStats, 2022)
• Home Health Care
  – ~11,500 home health agencies (2022)
  – ~3.3 million patients served annually (2022)
  (CDC)
• Hospice Care
  – ~5,800 hospice agencies (2022)
  – ~1.8 million patients (2020)
  (CDC)
• Residential Care Communities
  – ~32,200 communities (2022)
  – ~1,313,600 licensed beds (2022)
  – ~988,800 residents (2022)
  (CDC) 

Macro Tailwinds: Aging Population & Rising Care Needs

The U.S. is undergoing a major demographic shift toward an older population — significantly increasing demand across hospitals, long-term care facilities, and home health environments.

This aging trend is expected to continue accelerating care utilization and institutional capacity needs over the coming decades.

• The U.S. population age 65+ reached ~61.2 million (2024)
  (U.S. Census Bureau)
  

Broad and Expanding End-Market

Long-term care represents one of the largest and fastest-growing healthcare service categories globally.

Growth is primarily driven by the expanding geriatric population and rising chronic care needs worldwide.

• Global long-term care market size: $1.11 trillion (2023)
• Projected to reach $1.74 trillion by 2030
• CAGR: 6.6% (2024–2030)
• Source: Grand View Research

Usage Prevalence in Clinical Care

Bedpan reliance is widespread in immobilized patient populations:

• ~18.2% of acute-care patients required bedpan use during hospitalization
  (PubMed)

Contamination rates on surfaces containing waste

• Bedpan handling and emptying is linked to increased risk of healthcare-associated infections (HAIs) when decontamination is inadequate, and the literature repeatedly calls attention to the infection risk from manual handling and poor processing.
  (HospitalHealthcare)
• ~1 in 31 hospital patients has a healthcare-associated infection (HAI) on any given day.
  (CDC)
• U.S. HAIs cost between ~$7.2B and over $28B annually in direct medical expenses.
  (Washington State Department of Health)
• ~1.7M hospital patients contract HAIs annually in the U.S., contributing to ~98,000 deaths.
  (National Library of Medicine)

Where MyloPan™ fits

MyloPan targets high-frequency, everyday patient-care moments across:

1. System-level adoption (large networks/GPOs/government)
2. Direct facilities (nursing homes, rehab, hospice, long-term care)
3. Retail + e-commerce for at-home caregivers—creating multiple scalable paths to adoption

At some point in life, nearly everyone becomes a patient – or a caregiver for someone they love. A parent recovering from surgery. A grandparent in long-term care. A partner, sibling, or friend navigating vulnerability behind hospital doors. These moments are universal, yet deeply personal.

Mylo Medical exists for those moments.

Understanding that dignity in care is not abstract, it’s something you want for the people you love. It’s the quiet reassurance that someone is being treated with respect when they’re at their most vulnerable, even in the smallest, most overlooked interactions.

By supporting Mylo Medical, you can become part of a movement to raise the standard of everyday care – not through flashy technology, but through thoughtful design, empathy, and respect for the human experience. This journey is about transforming the moments patients never forget, and giving caregivers tools that honor the work they do every day.

Mylo is building a future where no one has to wonder whether their loved one is being cared for with dignity. You aren’t just backing a product by joining us – you’re helping redefine what compassionate healthcare looks like.